Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123847098 | 12384709 | 8 | F | 20160604 | 20160912 | 20160519 | 20160923 | PER | US-PFIZER INC-2016254470 | PFIZER | 51.00 | YR | M | Y | 111.00000 | KG | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123847098 | 12384709 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 123847098 | 12384709 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | Y | 21938 | CAPSULE, HARD | |||||||||
| 123847098 | 12384709 | 3 | C | BABY ASPIRIN | ASPIRIN | 1 | UNK | 0 | |||||||||||
| 123847098 | 12384709 | 4 | C | CITRACAL-D | 2 | UNK | 0 | ||||||||||||
| 123847098 | 12384709 | 5 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 123847098 | 12384709 | 6 | C | LUNESTA | ESZOPICLONE | 1 | UNK | 0 | |||||||||||
| 123847098 | 12384709 | 7 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 123847098 | 12384709 | 8 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123847098 | 12384709 | 1 | Gastrointestinal stromal tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123847098 | 12384709 | OT |
| 123847098 | 12384709 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123847098 | 12384709 | Abdominal pain | |
| 123847098 | 12384709 | Alopecia | |
| 123847098 | 12384709 | Arthralgia | |
| 123847098 | 12384709 | Chromaturia | |
| 123847098 | 12384709 | Constipation | |
| 123847098 | 12384709 | Decreased appetite | |
| 123847098 | 12384709 | Disease progression | |
| 123847098 | 12384709 | Dry skin | |
| 123847098 | 12384709 | Dysgeusia | |
| 123847098 | 12384709 | Faeces discoloured | |
| 123847098 | 12384709 | Faeces pale | |
| 123847098 | 12384709 | Fatigue | |
| 123847098 | 12384709 | Feeling hot | |
| 123847098 | 12384709 | Feeling of body temperature change | |
| 123847098 | 12384709 | Flank pain | |
| 123847098 | 12384709 | Gastrointestinal stromal tumour | |
| 123847098 | 12384709 | Gastrooesophageal reflux disease | |
| 123847098 | 12384709 | Haematocrit decreased | |
| 123847098 | 12384709 | Haemorrhage | |
| 123847098 | 12384709 | Hyperkeratosis | |
| 123847098 | 12384709 | Hypertension | |
| 123847098 | 12384709 | Insomnia | |
| 123847098 | 12384709 | Jaundice | |
| 123847098 | 12384709 | Liver function test increased | |
| 123847098 | 12384709 | Malaise | |
| 123847098 | 12384709 | Occult blood positive | |
| 123847098 | 12384709 | Ocular icterus | |
| 123847098 | 12384709 | Osteoporosis | |
| 123847098 | 12384709 | Pain | |
| 123847098 | 12384709 | Pain in extremity | |
| 123847098 | 12384709 | Skin fissures | |
| 123847098 | 12384709 | Tongue disorder | |
| 123847098 | 12384709 | White blood cell count decreased | |
| 123847098 | 12384709 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123847098 | 12384709 | 1 | 20160328 | 0 | ||
| 123847098 | 12384709 | 2 | 20160620 | 20160622 | 0 |